[go: up one dir, main page]

WO2006019984A3 - Compositions, procedes et trousses pour le diagnostic et le traitement du syndrome de mort subite du nourrisson - Google Patents

Compositions, procedes et trousses pour le diagnostic et le traitement du syndrome de mort subite du nourrisson Download PDF

Info

Publication number
WO2006019984A3
WO2006019984A3 PCT/US2005/025099 US2005025099W WO2006019984A3 WO 2006019984 A3 WO2006019984 A3 WO 2006019984A3 US 2005025099 W US2005025099 W US 2005025099W WO 2006019984 A3 WO2006019984 A3 WO 2006019984A3
Authority
WO
WIPO (PCT)
Prior art keywords
kits
compositions
diagnosis
methods
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/025099
Other languages
English (en)
Other versions
WO2006019984A2 (fr
Inventor
Steve A N Goldstein
Peter N Bowers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of WO2006019984A2 publication Critical patent/WO2006019984A2/fr
Anticipated expiration legal-status Critical
Publication of WO2006019984A3 publication Critical patent/WO2006019984A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention a trait à des procédés, des compositions et des trousses permettant l'identification de la présence d'un polymorphisme dans la protéine SCN5A du canal sodique cardiaque, en vue de l'identification de sujets à risque du syndrome de mort subite du nourrisson et l'identification de sujets portant le polymorphisme dans la protéine SCN5A de le canal sodique cardiaque.
PCT/US2005/025099 2004-07-15 2005-07-15 Compositions, procedes et trousses pour le diagnostic et le traitement du syndrome de mort subite du nourrisson Ceased WO2006019984A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58830204P 2004-07-15 2004-07-15
US60/588,302 2004-07-15
US67163105P 2005-04-14 2005-04-14
US60/671,631 2005-04-14

Publications (2)

Publication Number Publication Date
WO2006019984A2 WO2006019984A2 (fr) 2006-02-23
WO2006019984A3 true WO2006019984A3 (fr) 2009-04-09

Family

ID=35907913

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/025099 Ceased WO2006019984A2 (fr) 2004-07-15 2005-07-15 Compositions, procedes et trousses pour le diagnostic et le traitement du syndrome de mort subite du nourrisson

Country Status (1)

Country Link
WO (1) WO2006019984A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011503164A (ja) * 2007-11-12 2011-01-27 サムサラ・メディシン・アクチエボラーグ 呼吸障害に関連する方法
WO2015067857A1 (fr) 2013-11-08 2015-05-14 Modern Diagnostics Oy Procédé pour le criblage de facteurs de risques génétiques constituant une prédisposition ou une cause de décès chez le foetus ou le nourrisson
US12117453B2 (en) 2018-12-07 2024-10-15 Washington University Predicting patient response to sodium channel blockers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEN. S. ET AL.: "SNP S 1103Y In The Cardiac Sodium Channel Gene SCN5A Is Associated With Cardiac Arrhythmias And Sudden Death In A White Family.", JOURNAL OF MEDICAL GENETICS., vol. 39, 2002, pages 913 - 915 *

Also Published As

Publication number Publication date
WO2006019984A2 (fr) 2006-02-23

Similar Documents

Publication Publication Date Title
WO2007109236A3 (fr) Empreintes digitales micro-arn pendant une mégacaryocytopoïese
WO2004048938A3 (fr) Procedes de detection du sarcome des tissus mous, compositions et procedes de criblage des modulateurs du sarcome des tissus mous
WO2007137071A3 (fr) Compositions de r(+) et s(-) pramipéxole et procédés d'utilisation de celles-ci
WO2006020773A3 (fr) Procedes permettant de preparer des plaquettes lyophilisees, compositions contenant lesdites plaquettes lyophilisees, et procedes d'utilisation associes
WO2007007173A3 (fr) Nouveaux anticorps anti-madcam
WO2007016548A3 (fr) Procedes et compositions a base de micro-arn pour le diagnostic, le pronostic et le traitement du cancer du sein
WO2008100805A3 (fr) Anticorps anti-robo4 et utilisations de ceux-ci
WO2005014035A3 (fr) Utilisation de galactose oxydase pour la conjugaison chimique selective de molecules d'extraction a des proteines d'interet therapeutique
WO2004113277A8 (fr) Procedes et compositions de traitement de maladies associees aux amyloides
EA201590833A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
WO2006020269A3 (fr) Biomarqueurs de maladie neurodegenerative
WO2008042231A3 (fr) Compositions et méthodes d'évaluation et de traitement de l'insuffisance cardiaque
GB0421639D0 (en) Methods and compositions relating to alzheimer's disease
WO2005067546A3 (fr) Derives et analogues de pyrrolopyrimidine et utilisation de ceux-ci dans le traitement a la prevention de maladies
WO2007041245A3 (fr) Marqueurs biologiques de la sclerose en plaques et methodes d'utilisation de ceux-ci
WO2006066008A3 (fr) Dispositif et procedes pour l'identification et le traitement de patients ne reagissant pas a l'aspirine
AP2359A (en) Sulfonamide derivatives for the treatment of diseases.
WO2005098445A3 (fr) Biomarqueurs de cancer du poumon
WO2005117938A3 (fr) Methodes de traitement des pathologies oculaires
WO2008112898A3 (fr) Modifications génétiques sur le chromosome 12 et procédés d'utilisation de celles-ci pour le diagnostic et le traitement du diabète de type i
WO2006059252A3 (fr) Procedes et compositions fluorees pour le traitement de maladies associees aux amyloides
WO2007032876A3 (fr) Marqueurs biologiques associés à la dégénérescence maculaire liée à l'âge
WO2004045376A3 (fr) Methodes de criblage permettant d'identifier des traitements contre une maladie auto-immune
WO2006119775A3 (fr) Procede de diagnostic et de traitement d'une maladie mentale
WO2004081199A3 (fr) Nouvelles compositions et methodes de traitement de troubles du systeme immunitaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase